Literature DB >> 21338608

Hypoxia exacerbates Ca(2+)-handling disturbances induced by very low density lipoproteins (VLDL) in neonatal rat cardiomyocytes.

José Castellano1, Jordi Farré, Jacqueline Fernandes, Antoni Bayes-Genis, Juan Cinca, Lina Badimon, Leif Hove-Madsen, Vicenta Llorente-Cortés.   

Abstract

It is known that myocardium suffers serious alterations under ischemic conditions such as lipid overloading and electrophysiological alterations. However, it is unknown whether intracellular lipid accumulation and calcium dysfunction share common pathophysiological mechanisms under ischemia. The aims of this study were 1) to analyze the effect of normal and high doses of very low density lipoproteins (VLDL) on lipid content and calcium handling; 2) to investigate whether hypoxia modulates the effect of high VLDL doses; and 3) to identify potentially underlying mechanisms in cardiomyocytes. For this purpose, neonatal rat ventricular myocytes cultures were prepared from hearts of 3-4-day-old rats. High doses of VLDL that induced cholesteryl ester (CE) and triglyceride (TG) accumulation strongly reduced sarco(endo)plasmic reticulum Ca ATPase-2 (SERCA-2) expression, calcium transient amplitude and sarcoplasmic reticulum (SR) calcium loading. Interestingly, hypoxia, by upregulating VLDL-receptor expression (4.5-fold at 16h) increased CE (1.5-fold) and TG (3-fold) cardiomyocyte content and exacerbated the negative effect of VLDL on SERCA-2 expression. Functionally, the hypoxic exacerbation of VLDL-mediated SERCA-2 downregulation was translated into a stronger decrease in calcium transient amplitude and SR calcium loading in myocytes exposed simultaneously to hypoxia and high VLDL. In conclusion, high VLDL doses alter calcium handling in cardiomyocytes and SERCA-2 play a pivotal role in the hypoxic exacerbation of VLDL-mediated effects on cardiac calcium handling. Potentiation of VLDL's effects under hypoxia is explained, at least in part, by hypoxic upregulation of the expression of VLDL-receptor.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338608     DOI: 10.1016/j.yjmcc.2011.02.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication.

Authors:  Joseph Wider; Vishnu V R Undyala; Peter Whittaker; James Woods; Xuequn Chen; Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2018-03-09       Impact factor: 17.165

2.  Mesencephalic astrocyte-derived neurotrophic factor protects the heart from ischemic damage and is selectively secreted upon sarco/endoplasmic reticulum calcium depletion.

Authors:  Christopher C Glembotski; Donna J Thuerauf; Chengqun Huang; John A Vekich; Roberta A Gottlieb; Shirin Doroudgar
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

3.  Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients.

Authors:  Roi Cal; Oriol Juan-Babot; Vicenç Brossa; Santiago Roura; Carolina Gálvez-Montón; Manolo Portoles; Miguel Rivera; Juan Cinca; Lina Badimon; Vicenta Llorente-Cortés
Journal:  J Transl Med       Date:  2012-08-08       Impact factor: 5.531

4.  Very-low-density lipoprotein: complex particles in cardiac energy metabolism.

Authors:  You-Guo Niu; Rhys D Evans
Journal:  J Lipids       Date:  2011-07-03

5.  Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes.

Authors:  D de Gonzalo-Calvo; R W van der Meer; L J Rijzewijk; J W A Smit; E Revuelta-Lopez; L Nasarre; J C Escola-Gil; H J Lamb; V Llorente-Cortes
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

6.  Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy.

Authors:  Aleyda Benitez-Amaro; Valerie Samouillan; Esther Jorge; Jany Dandurand; Laura Nasarre; David de Gonzalo-Calvo; Olga Bornachea; Gerard Amoros-Figueras; Colette Lacabanne; David Vilades; Ruben Leta; Francesc Carreras; Alberto Gallardo; Enrique Lerma; Juan Cinca; Jose M Guerra; Vicenta Llorente-Cortés
Journal:  J Cell Mol Med       Date:  2018-06-19       Impact factor: 5.310

7.  Low density lipoproteins promote unstable calcium handling accompanied by reduced SERCA2 and connexin-40 expression in cardiomyocytes.

Authors:  Montserrat Barriga; Roi Cal; Nuria Cabello; Anna Llach; Alexander Vallmitjana; Raúl Benítez; Lina Badimon; Juan Cinca; Vicenta Llorente-Cortés; Leif Hove-Madsen
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

8.  VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation.

Authors:  Hsiang-Chun Lee; Hsin-Ting Lin; Liang-Yin Ke; Chi Wei; Yi-Lin Hsiao; Chih-Sheng Chu; Wen-Ter Lai; Shyi-Jang Shin; Chu-Huang Chen; Sheng-Hsiung Sheu; Bin-Nan Wu
Journal:  Int J Mol Sci       Date:  2016-01-20       Impact factor: 5.923

9.  Adipose differentiation-related protein is not involved in hypoxia inducible factor-1-induced lipid accumulation under hypoxia.

Authors:  Guomin Shen; Ning Ning; Xingsheng Zhao; Xi Liu; Guangyu Wang; Tianzhen Wang; Ran Zhao; Chao Yang; Dongmei Wang; Pingyuan Gong; Yan Shen; Yongjian Sun; Xiao Zhao; Yinji Jin; Weiwei Yang; Yan He; Lei Zhang; Xiaoming Jin; Xiaobo Li
Journal:  Mol Med Rep       Date:  2015-10-26       Impact factor: 2.952

10.  Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus.

Authors:  David de Gonzalo-Calvo; Cristina Colom; David Vilades; Andrea Rivas-Urbina; Abdel-Hakim Moustafa; Montserrat Pérez-Cuellar; Jose Luis Sánchez-Quesada; Antonio Pérez; Vicenta LLorente-Cortes
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.